Rick Bartram

No open positions remaining

Net worth: 2 M $ as of 30/05/2026

45 year

85 connections

Health Technology

Commercial Services

Consumer Services

Profile

Richard B. Bartram worked at PricewaterhouseCoopers LLP from 2005 to 2013 as an Assurance Manager.
From 2013 to 2022, worked at Esperion Therapeutics, Inc., serving as Vice President-Finance from 2015 to 2018.
From 2022 to 2026, worked at MBX Biosciences, Inc. as Chief Financial Officer.
Attended Michigan State University for undergraduate and graduate degrees.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MBX BIOSCIENCES, INC. 0.1%	09/04/2026	48,757 ( 0.1% )	2 M $	30/05/2026

Former positions of Rick Bartram

Companies	Position	End
MBX BIOSCIENCES, INC.	Director of Finance/CFO	14/05/2026
ESPERION THERAPEUTICS, INC.	Director of Finance/CFO	07/04/2022
PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services	Corporate Officer/Principal	31/01/2013

See the detail of Rick Bartram's experience

Training of Rick Bartram

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rick Bartram's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Esperion Therapeutics, Inc. Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products	Health Technology
PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services	Commercial Services
Michigan State University Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MBX Biosciences, Inc. MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders	Health Technology